United Services Automobile Association Biocryst Pharmaceuticals Inc Transaction History

United Services Automobile Association

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$2.5 - $3.73 $36,942 - $55,118	-14,777 Closed	0 $0
Q2 2018 Sep 27, 2018	SELL	$4.6 - $6.52 $966,832 - $1.37 Million	-210,181 Reduced 93.43%	14,777 $85,000
Q2 2018 Aug 10, 2018	BUY	$4.6 - $6.52 $966,832 - $1.37 Million	210,181 Added 1422.35%	224,958 $14.9 Million
Q1 2018 May 14, 2018	BUY	$4.35 - $5.82 $64,279 - $86,002	14,777 New	14,777 $70,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.